Moreover, we previously showed that OPCs in MS lesions express Sema3F receptor, neuropilin 2 (Nrp2), and that while Sema3F is detected in early lesions, it is not expressed in chronically demyelinated lesions (Williams et al, 2007). This evidence concerns the gene NRP2 and myeloid sarcoma.